Fingerprint
Dive into the research topics of 'Bevacizumab combined with gemcitabine and capecitabine for advanced pancreatic cancer: A phase II study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Bevacizumab combined with gemcitabine and capecitabine for advanced pancreatic cancer: A phase II study
M. Javle, J. Yu, C. Garrett, A. Pande, B. Kuvshinoff, A. Litwin, J. Phelan, J. Gibbs, R. Iyer
Research output: Contribution to journal › Article › peer-review
32
Scopus
citations